Modulatory effects on dendritic cells by human herpesvirus 6

por Gustafsson, Rasmus, Svensson, Mattias, Fogdell-Hahn, Anna
Publicado 2015

The role of herpesvirus 6A and 6B in multiple sclerosis and epilepsy

por Dunn, Nicky, Kharlamova, Nastya, Fogdell‐Hahn, Anna
Publicado 2020

Long-Term Consequences of High Titer Neutralizing Antibodies to Interferon-β in Multiple Sclerosis

por Dunn, Nicky, Fogdell-Hahn, Anna, Hillert, Jan, Spelman, Tim
Publicado 2020

Development and validation of a Q-PCR based TCID(50) method for human herpesvirus 6

por Gustafsson, Rasmus K L, Engdahl, Elin E, Fogdell-Hahn, Anna
Publicado 2012

Purification of infectious human herpesvirus 6A virions and association of host cell proteins

por Hammarstedt, Maria, Ahlqvist, Jenny, Jacobson, Steven, Garoff, Henrik, Fogdell-Hahn, Anna
Publicado 2007

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis

por Warnke, Clemens, Stüve, Olaf, Hartung, Hans-Peter, Fogdell-Hahn, Anna, Kieseier, Bernd C
Publicado 2011

Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes

por Ahlqvist, Jenny, Fotheringham, Julie, Akhyani, Nahid, Yao, Karen, Fogdell-Hahn, Anna, Jacobson, Steven
Publicado 2005

First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitis

por Faustini, Francesca, Dunn, Nicky, Kharlamova, Nastya, Ryner, Malin, Bruchfeld, Annette, Malmström, Vivianne, Fogdell-Hahn, Anna, Gunnarsson, Iva
Publicado 2021

Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity

por Faustini, Francesca, Sippl, Natalie, Stålesen, Ragnhild, Chemin, Karine, Dunn, Nicky, Fogdell-Hahn, Anna, Gunnarsson, Iva, Malmström, Vivianne
Publicado 2022

Multiple Sclerosis Patients with Markedly Low Intrathecal Antibody Response in Sri Lanka

por Gamage, S. M. K., Wijeweera, I., Adikari, S. B., Fink, Katharina, Hillert, Jan, Fogdell-Hahn, Anna, Sominanda, H. M. A.
Publicado 2018

A Genetic Association Test Accounting for Skewed X-Inactivation With Application to Biotherapy Immunogenicity in Patients With Autoimmune Diseases

por Hässler, Signe, Camilleri-Broët, Sophie, Allez, Matthieu, Deisenhammer, Florian, Fogdell-Hahn, Anna, Mariette, Xavier, Pallardy, Marc, Broët, Philippe
Publicado 2022

Human Leukocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis

por Link, Jenny, Lundkvist Ryner, Malin, Fink, Katharina, Hermanrud, Christina, Lima, Izaura, Brynedal, Boel, Kockum, Ingrid, Hillert, Jan, Fogdell-Hahn, Anna
Publicado 2014

Physical exercise is associated with a reduction in plasma levels of fractalkine, TGF-β1, eotaxin-1 and IL-6 in younger adults with mobility disability

por Kumar, Parvin, Stiernborg, Miranda, Fogdell-Hahn, Anna, Månsson, Kristoffer, Furmark, Tomas, Berglind, Daniel, Melas, Philippe A., Forsell, Yvonne, Lavebratt, Catharina
Publicado 2022

Human Herpesvirus 6A Partially Suppresses Functional Properties of DC without Viral Replication

por Gustafsson, Rasmus K. L., Engdahl, Elin E., Hammarfjord, Oscar, Adikari, Sanjaya B., Lourda, Magda, Klingström, Jonas, Svensson, Mattias, Fogdell-Hahn, Anna
Publicado 2013

Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment

por Persson Berg, Linn, Eriksson, Marcus, Longhi, Sonia, Kockum, Ingrid, Warnke, Clemens, Thomsson, Elisabeth, Bäckström, Malin, Olsson, Tomas, Fogdell-Hahn, Anna, Bergström, Tomas
Publicado 2022

Drug Tolerant Anti-drug Antibody Assay for Infliximab Treatment in Clinical Practice Identifies Positive Cases Earlier

por Kharlamova, Nastya, Hermanrud, Christina, Dunn, Nicky, Ryner, Malin, Hambardzumyan, Karen, Vivar Pomiano, Nancy, Marits, Per, Gjertsson, Inger, Saevarsdottir, Saedis, Pullerits, Rille, Fogdell-Hahn, Anna
Publicado 2020

A Machine Learning Approach for High-Dimensional Time-to-Event Prediction With Application to Immunogenicity of Biotherapies in the ABIRISK Cohort

por Duhazé, Julianne, Hässler, Signe, Bachelet, Delphine, Gleizes, Aude, Hacein-Bey-Abina, Salima, Allez, Matthieu, Deisenhammer, Florian, Fogdell-Hahn, Anna, Mariette, Xavier, Pallardy, Marc, Broët, Philippe
Publicado 2020

Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus

por Wincup, Chris, Dunn, Nicky, Ruetsch-Chelli, Caroline, Manouchehrinia, Ali, Kharlamova, Nastya, Naja, Meena, Seitz-Polski, Barbara, Isenberg, David A, Fogdell-Hahn, Anna, Ciurtin, Coziana, Jury, Elizabeth C
Publicado 2022

Assessing the effect of genetic markers on drug immunogenicity from a mechanistic model-based approach

por Duhazé, Julianne, Caubet, Miguel, Hässler, Signe, Bachelet, Delphine, Allez, Matthieu, Deisenhammer, Florian, Fogdell-Hahn, Anna, Gleizes, Aude, Hacein-Bey-Abina, Salima, Mariette, Xavier, Pallardy, Marc, Broët, Philippe
Publicado 2020

Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ

por Waddington, Kirsty E., Papadaki, Artemis, Coelewij, Leda, Adriani, Marsilio, Nytrova, Petra, Kubala Havrdova, Eva, Fogdell-Hahn, Anna, Farrell, Rachel, Dönnes, Pierre, Pineda-Torra, Inés, Jury, Elizabeth C.
Publicado 2020